Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. https://doi.org/10.1001/archpsyc.62.6.593.

Article  PubMed  Google Scholar 

Kessler RC, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27. https://doi.org/10.1001/archpsyc.62.6.617.

Article  PubMed  PubMed Central  Google Scholar 

• Arnold I, Dehning J, Grunze A, Hausmann A. Old age bipolar disorder-epidemiology, aetiology and treatment. Medicina (Kaunas). 2021;57(6):587. https://doi.org/10.3390/medicina57060587. PMID: 34201098; PMCID: PMC8226928. This review highlights the specificities of OABD and the implications for treatment.

Depp CA, et al. Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis. 2004;192(11):796–9. https://doi.org/10.1097/01.nmd.0000145055.45944.d6.

Article  PubMed  Google Scholar 

Lavin P, Buck G, Almeida OP, Su CL, Eyler LT, Dols A, Blumberg HP, Forester BP, Forlenza OV, Gildengers A, Mulsant BH, Tsai SY, Vieta E, Schouws S, Briggs FBS, Sutherland A, Sarna K, Yala J, Orhan M, Korten N, Sajatovic M, Rej S, GAGE-BD Investigators. Clinical correlates of late-onset versus early-onset bipolar disorder in a global sample of older adults. Int J Geriatr Psychiatry. 2022;37(12). https://doi.org/10.1002/gps.5833. Epub ahead of print. PMID: 36317317.

Maia da Silva MN, Porto FHG, Lopes PMG, Sodré de Castro Prado C, Frota NAF, Alves CHL, Alves GS. Frontotemporal dementia and late-onset bipolar disorder: the many directions of a busy road. Front Psychiatry. 2021;12:768722. https://doi.org/10.3389/fpsyt.2021.768722. PMID: 34925096; PMCID: PMC8674641.

Article  PubMed  PubMed Central  Google Scholar 

Barbosa IG, Bauer ME, Teixeira AL. Chapter 12 - Neuroimmune pathways in bipolar disorder. In: Machado-Vieira R, Soares JC, editors. Biomarkers in bipolar disorders. Academic Press; 2022. p. 191–214. https://doi.org/10.1016/B978-0-12-821398-8.00003-5. ISBN 9780128213988.

Chapter  Google Scholar 

•• Teixeira AL, et al. Biomarkers for bipolar disorder: current status and challenges ahead. Expert Rev Neurother. 2019;19(1):67–81. https://doi.org/10.1080/14737175.2019.1550361. This review assesses the current status of biomarkers for bipolar disorder in the general population.

Article  CAS  PubMed  Google Scholar 

Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013;381(9878):1654–62. https://doi.org/10.1016/S0140-6736(13)60855-7.

Article  CAS  PubMed  Google Scholar 

Medeiros GC, Goes FS. Chapter 8 - Genome-wide association study biomarkers in bipolar disorder. In: Machado-Vieira R, Soares JC, editors. Biomarkers in bipolar disorders. Academic Press; 2022. p. 125–39. https://doi.org/10.1016/B978-0-12-821398-8.00016-3. ISBN 9780128213988.

Chapter  Google Scholar 

Grewal S, et al. Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review. Aust N Z J Psychiatry. 2023;57(3):328–43. https://doi.org/10.1177/00048674221091731.

Article  PubMed  Google Scholar 

Camkurt MA, Mwangi B, Sanches M, Soares JC. Chapter 5 - Structural neuroimaging markers in bipolar disorder. In: Machado-Vieira R, Soares JC, editors. Biomarkers in bipolar disorders. Academic Press; 2022. p. 81–93. https://doi.org/10.1016/B978-0-12-821398-8.00019-9. ISBN 9780128213988.

Chapter  Google Scholar 

Vecera CM, Chong AC, Ruiz AC, Rong C, Jones G, Machado-Vieira R, Soares JC. Chapter 6 - Magnetic resonance spectroscopy in bipolar disorder. In: Machado-Vieira R, Soares JC, editors. Biomarkers in bipolar disorders. Academic Press; 2022. p. 95–113. https://doi.org/10.1016/B978-0-12-821398-8.00030-8. ISBN 9780128213988.

Chapter  Google Scholar 

Birur B, et al. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature. NPJ Schizophr. 2017;3:15. https://doi.org/10.1038/s41537-017-0013-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol. 2012;25(1):20–5. https://doi.org/10.1177/0891988712436683.

Article  PubMed  Google Scholar 

Daban C, et al. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review Psychother Psychosom. 2006;75(2):72–84. https://doi.org/10.1159/000090891.

Article  PubMed  Google Scholar 

Krabbendam L, et al. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res. 2005;80(2–3):137–49. https://doi.org/10.1016/j.schres.2005.08.004.

Article  PubMed  Google Scholar 

Moher D, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1.

Article  PubMed  PubMed Central  Google Scholar 

Wirsching J, et al. Development and reliability assessment of a new quality appraisal tool for cross-sectional studies using biomarker data (BIOCROSS). BMC Med Res Methodol. 2018;18(1):122. https://doi.org/10.1186/s12874-018-0583-x.

Article  PubMed  PubMed Central  Google Scholar 

Van Den Bogaert A, et al. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry. 2006;63(10):1103–10. https://doi.org/10.1001/archpsyc.63.10.1103.

Article  PubMed  Google Scholar 

Altamura AC, Buoli M, Pozzoli S. Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia. Psychiatry Clin Neurosci. 2014;68(1):21–36. https://doi.org/10.1111/pcn.12089.

Article  CAS  PubMed  Google Scholar 

Kato T, et al. Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder. J Hum Genet. 2011;56(11):779–83. https://doi.org/10.1038/jhg.2011.101.

Article  CAS  PubMed  Google Scholar 

Hattori E, et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(8):1110–7. https://doi.org/10.1002/ajmg.b.30941.

Article  CAS  PubMed  Google Scholar 

Luykx JJ, Giuliani F, Giuliani G, Veldink J. Coding and non-coding RNA abnormalities in bipolar disorder. Genes (Basel). 2019;10(11):946. https://doi.org/10.3390/genes10110946. PMID: 31752442; PMCID: PMC6895892.

Article  CAS  PubMed  Google Scholar 

Banigan MG, et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE. 2013;8(1): e48814. https://doi.org/10.1371/journal.pone.0048814.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Guo L, et al. Quantification of Tyrosine Hydroxylase and ErbB4 in the Locus Coeruleus of Mood Disorder Patients Using a Multispectral Method to Prevent Interference with Immunocytochemical Signals by Neuromelanin. Neurosci Bull. 2019;35(2):205–15. https://doi.org/10.1007/s12264-019-00339-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbosa IG, Rocha NP, Huguet RB, Ferreira RA, Salgado JV, Carvalho LA, Pariante CM, Teixeira AL. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers. J Affect Disord. 2012;137(1–3):151–5. https://doi.org/10.1016/j.jad.2011.12.034. Epub 2012 Jan 16. PMID: 22252095.

Article  CAS  PubMed  Google Scholar 

Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR, Yang SH. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719. https://doi.org/10.3390/ijms22052719. PMID: 33800290; PMCID: PMC7962638.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbosa IG, Rocha NP, Huebra L, Oliveira C, Nobre V, Teixeira AL. Notall inflammatory biomarkers are elevated in bipolar disorder: evidence forprocalcitonin. Biol Psychiatry. 2013;74(10):e29–30. https://doi.org/10.1016/j.biopsych.2013.03.010. Epub 2013 Apr 17. PMID: 23601849.

Article  CAS  PubMed  Google Scholar 

Traverse S, et al. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol. 1994;4(8):694–701. https://doi.org/10.1016/s0960-9822(00)00154-8.

Article  CAS  PubMed  Google Scholar 

Skibinska M, Kapelski P, Dmitrzak-Weglarz M, Lepczynska N, Pawlak J, Twarowska-Hauser J, Szczepankiewicz A, Rajewska-Rager A. Elevated epidermal growth factor (EGF) as candidate biomarker of mood disorders-longitudinal study in adolescent and young adult patients. J Clin Med. 2021;10(18):4064. https://doi.org/10.3390/jcm10184064. PMID: 34575175; PMCID: PMC8468978.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berk M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011;35(3):804–17. https://doi.org/10.1016/j.neubiorev.2010.10.001.

Article  CAS  PubMed  Google Scholar 

Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians. 1999;111(5):383–9. https://doi.org/10.1111/paa.1999.111.5.383. PMID: 10519157.

Article  CAS  PubMed  Google Scholar 

Yamamori H, et al. Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population. Neurosci Lett. 2016;612:167–71. https://doi.org/10.1016/j.neulet.2015.12.019.

Article  CAS  PubMed  Google Scholar 

Johnson LL, Dyer R, Hupe DJ. Matrix metalloproteinases. Curr Opin Chem Biol. 1998;2(4):466–71. https://doi.org/10.1016/s1367-5931(98)80122-1. PMID: 9736919.

Article  CAS  PubMed  Google Scholar